Projects

Advocacy for the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) project
MMGH/Carsten Mantel
2019
Ongoing
Advocacy for the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) project

MMGH is part of the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) consortium, made up of 12 partners from eight different countries including three disease-endemic countries. The initiative ...

Client:

European Commission

MR-MAPs initial Full Vaccine Value Assessment
2021
Ongoing
MR-MAPs initial Full Vaccine Value Assessment

In partnership with the London School of Hygiene and Tropical Medicine and Global Health Visions, support the development of an initial Full Vaccine Value Assessment of Measles-Rubella micro-array patches ...

Client:

UNICEF

Definition and market sizing of the use cases for micro-array patches for Measles-Rubella vaccine
2019
Ongoing
Definition and market sizing of the use cases for micro-array patches for Measles-Rubella vaccine

MMGH supports the WHO's Vaccine Product & Delivery Research department in defining and sizing (including a demand forecast) the use cases for a Measles Rubella vaccine micro-array patch (MAP). The use ...

Client:

World Health Organization (WHO)

Development of European Region Immunization Agenda 2030
2019
2020
Development of European Region Immunization Agenda 2030

MMGH supported the Bill & Melinda Gates Foundation in assessing the public health and financial viability of a macrofilaricide drug to accelerate the elimination of onchocerciasis. MMGH coordinated the ...

Client:

Bill & Melinda Gates Foundation

Definition and market sizing of the use cases for micro-array patches for Typhoid Conjugate vaccines
2021
Ongoing
Definition and market sizing of the use cases for micro-array patches for Typhoid Conjugate vaccines

MMGH is supporting the Vaccine Innovation Prioritization Strategy on defining potential use cases for Typhoid Conjugate Vaccine microarray patches (TCV-MAPs) this work will include a demand forecast of ...

Client:

Gavi, the Vaccine Alliance

Demand forecast and financial sustainability analysis for a group B streptococcal vaccine
CDC
2019
2020
Demand forecast and financial sustainability analysis for a group B streptococcal vaccine

MMGH supported the WHO Initiative for Vaccine Research (IVR) in developing a variety of forecast scenarios for the demand of a group B streptococcal (GBS) vaccine administered through maternal immunisation. ...

Client:

World Health Organization (WHO)